InnoCare Receives CDE Approval for Phase II Trial of Orelabrutinib Combination
China-based biopharma InnoCare Pharma (HKG: 9969, SHA: 688428) has announced receiving approval from China’s Center...
Fineline Cube
Ronovo Surgical Raises Pre-Series B Funding for Surgical Robot Development
Ronovo Surgical, a minimally invasive surgery device maker based in Shanghai, has reportedly raised “tens...
PingAn Good Doctor Partners to Establish Lifestyle Medicine
China-based PingAn Healthcare and Technology Co., Ltd (HKG: 1833), also known as PingAn Good Doctor,...
JW Therapeutics Collaborates with Juno for DLL3 CAR-T Therapy Development
China-based JW Therapeutics Co., Ltd (HKG: 2126) has issued a stock exchange announcement revealing a...
Mabwell Bioscience Licenses Biosimilars to Russian Firm Binnopharm
China-based Mabwell Bioscience (SHA: 688062) has announced the establishment of a licensing agreement with the...
Sirnaomics’ Lead Candidate STP707 Shows Promising Phase I Data
Sino-US small interfering RNA (siRNA) specialist Sirnaomics (HKG: 2257) has revealed that its lead pipeline...
Kira Pharmaceuticals Gains NMPA and TGA Approvals for KP104 Phase II Study
Sino-US biotech Kira Pharmaceuticals has announced receiving approvals from China’s National Medical Products Administration (NMPA)...
TowardPi Raises RMB 300 Million in Series C Financing Round
China-based ophthalmology device maker TowardPi (Beijing) Medical Technology Ltd has reportedly raised close to RMB...
Aosaikang Receives FDA Approval for ASKG915 Clinical Trial
Beijing Aosaikang Pharmaceutical Co., Ltd (SHE: 002755) has announced receiving clinical trial approval for its...
Pfizer Exercises Option for Sisunatovir Rights with LianBio
US major Pfizer Inc. (NYSE: PFE) has agreed with China-based LianBio (OTCMKTS: LIANY) to exercise...
Fosun Pharma Registers Comirnaty Vaccines in Hong Kong
Shanghai Fosun Pharmaceutical Group Co (SHA: 600196) has announced that Comirnaty (BNT162b2) and Comirnaty bivalent...
XtalPi Partners with Singapore’s EDDC to Develop Lung Cancer Treatments
Sino-US artificial intelligence (AI) firm XtalPi Inc. has struck a partnership with the Experimental Drug...
Prenetics Acquires Majority Stake in ACT Genomics to Boost Oncology Services
Hong Kong-based Prenetics Global Ltd (NASDAQ: PRE) has announced the acquisition of a majority stake...
CStone’s Sugemalimab MAA Accepted by UK MHRA for NSCLC Treatment
China-based CStone Pharmaceuticals (HKG: 2616) has announced that the Medicines and Healthcare products Regulatory Agency...
Ascletis Pharma Receives USPTO Notice for ASC10 Patent
China-based Ascletis Pharma Inc. (HKG: 1672) has announced receiving the Notice of Issuance from the...
HutchMed Initiates Rolling NDA Submission for Elunate to US FDA
Hutchison China Meditech (HutchMed; HKG: 0013, NASDAQ: HCM) has announced the initiation of a rolling...
PCAOB Report Signals Relief for US-Listed Chinese Biotechs
A report issued last week by the US Public Company Accounting Oversight Board (PCAOB) indicated...
Luye Pharma’s Shandong Boan Biotechnology IPOs on Hong Kong Stock Exchange
China-based Luye Pharma Group’s (HKG: 2186) controlling subsidiary Shandong Boan Biotechnology Co., Ltd has officially...
Simcere Pharmaceutical Completes Enrollment for SIM0417 COVID-19 Drug Trial
China-based Simcere Pharmaceutical Group (HKG: 2096) has announced the completion of enrollment of 1,208 patients...
Neurophth’s NFS-02 Gene Therapy Gets FDA IND Approval for LHON Treatment
China-based gene therapy specialist Neurophth Biotechnology Ltd has announced obtaining Investigational New Drug (IND) approval...